Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Twenty healthy men and twelve patients with hypertensive type neurocirculatory
dystonia
belonging to the flying personnel were examined. They breathed a hypercapnic-hypoxia mixture formed during rebreathing in a closed circuit without a
CO2
adsorber. In both groups this provocative test produced similar variations of most parameters under study. However in contrast to the healthy men, the hypertensive subjects showed a lower compensatory hyperventilation, a greater increase of blood pressure and cardiac output and a relatively small decrease of total peripheral resistance. Three test subjects displayed sinus arrhythmia. The time of test tolerance in the patients was on the average 20% shorter than in the healthy subjects. The changes can be viewed as an indication that the reserve capability of the cardiorespiratory system declines. The fact that the test is rapid, simple and safe makes it possible to use it during regular medical monitoring of the flying personnel with functional disorders of the cardiovascular system.
...
PMID:[Effect of the hypercapnic-hypoxic test on cardiovascular parameters in individuals with neurocirculatory dystonia]. 343 46
Tetrahydrobiopterin (BH4) is synthesized from guanosine triphosphate (GTP) by GTP cyclohydrolase I (GCH), 6-pyruvoyltetrahydropterin synthase (PTS), and sepiapterin reductase (SPD). GCH is the rate-limiting enzyme. BH4 is a cofactor for three pteridine-requiring monooxygenases that hydroxylate aromatic L-amino acids, i.e., tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and phenylalanine hydroxylase (PAH), as well as for nitric oxide synthase (NOS). The intracellular concentrations of BH4, which are mainly determined by GCH activity, may regulate the activity of TH (an enzyme-synthesizing catecholamines from tyrosine), TPH (an enzyme-synthesizing serotonin and melatonin from tryptophan), PAH (an enzyme required for complete degradation of phenylalanine to tyrosine, finally to
CO2
+ H2O), and also the activity of NOS (an enzyme forming NO from arginine), Dominantly inherited hereditary progressive
dystonia
(HPD), also termed DOPA-responsive
dystonia
(DRD) or Segawa's disease, is a dopamine deficiency in the nigrostriatal dopamine neurons, and is caused by mutations of one allele of the GCH gene. GCH activity and BH4 concentrations in HPD/DRD are estimated to be 2-20% of the normal value. By contrast, recessively inherited GCH deficiency is caused by mutations of both alleles of the GCH gene, and the GCH activity and BH4 concentrations are undetectable. The phenotypes of recessive GCH deficiency are severe and complex, such as hyperphenylalaninemia, muscle hypotonia, epilepsy, and fever episode, and may be caused by deficiencies of various neurotransmitters, including dopamine, norepinephrine, serotonin, and NO. The biosynthesis of dopamine, norepinephrine, epinephrine, serotonin, melatonin, and probably NO by individual pteridine-requiring enzymes may be differentially regulated by the intracellular concentration of BH4, which is mainly determined by GCH activity. Dopamine biosynthesis in different groups of dopamine neurons may be differentially regulated by TH activity, depending on intracellular BH4 concentrations and GCH activity. The nigrostriatal dopamine neurons may be most susceptible to a partial decrease in BH4, causing dopamine deficiency in the striatum and the HPD/DRD phenotype.
...
PMID:Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin. 1032 73